Evaluating spatially targeted HIV interventions and harm reduction services among people who inject drugs in a high-burden setting
- PMID: 41730912
- DOI: 10.1038/s41467-026-69874-3
Evaluating spatially targeted HIV interventions and harm reduction services among people who inject drugs in a high-burden setting
Abstract
People who inject drugs (PWID) in India continue to experience high HIV incidence while coverage of HIV and harm reduction services within this population remains suboptimal in many settings, highlighting the need to identify novel service delivery points. To evaluate the effectiveness of spatially focused upscaling of interventions at observed venues where PWID injected drugs together, we developed an individual-based dynamic transmission model of HIV informed by detailed injection network, service engagement, and injection venue attendance data collected in a sociometric study of PWID (n = 2512) in New Delhi, India. HIV incidence was simulated for different spatial targeting strategies and with increasing service coverage at injection venues according to UNAIDS/UNODC goals. We identified significant decreases in predicted HIV incidence when deploying interventions at frequently visited injection venues (from 6.8 cases/100 person-years to 2.7/100PY for full service coverage at the most-visited venue, and further down to 1.3/100PY for 12 most-visited venues). Prioritizing the most visited venues stratified by spatial clusters provided services to a larger number of individuals versus prioritizing the overall most visited venues, suggesting that service expansion at venues that are spatially distinct with minimal population overlap has a slightly larger impact on reducing HIV incidence.
© 2026. The Author(s).
Conflict of interest statement
Competing interests: S.H.M. reports personal fees from Gilead Sciences outside the submitted work. S.S.S. reports grants/products and speaker fees from Gilead Sciences and grants/products from Abbott Diagnostics outside the submitted work. The remaining authors declare no competing interests.
References
-
- Larney, S. et al. Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence. Int. J. Drug Policy 77, 102656 (2020).
-
- Des Jarlais, D. C. et al. HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks. AIDS 30, 815–826 (2016).
-
- Arum, C. et al. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health 6, e309–e323 (2021).
-
- Pachuau, L. N. et al. HIV among people who inject drugs in India: a systematic review. BMC Public Health 22, 1529 (2022).
-
- Degenhardt, L. et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob. Health 5, e1192–e1207 (2017).
Grants and funding
- 2327751/National Science Foundation (NSF)
- 2327751/National Science Foundation (NSF)
- DP2DA056130/U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)
- R01DA041736/U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)
- DP1DA060602/U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA)
LinkOut - more resources
Full Text Sources
